{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418521477028992.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s00467-009-1214-x"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00467-009-1214-x.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s00467-009-1214-x/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00467-009-1214-x"}}],"dc:title":[{"@value":"T regulatory cell function in idiopathic minimal lesion nephrotic syndrome"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418521477028995","@type":"Researcher","foaf:name":[{"@value":"Carlos Araya"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521477028992","@type":"Researcher","foaf:name":[{"@value":"Leila Diaz"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521477028864","@type":"Researcher","foaf:name":[{"@value":"Clive Wasserfall"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521477028993","@type":"Researcher","foaf:name":[{"@value":"Mark Atkinson"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521477028997","@type":"Researcher","foaf:name":[{"@value":"Wei Mu"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521477028996","@type":"Researcher","foaf:name":[{"@value":"Richard Johnson"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521477028994","@type":"Researcher","foaf:name":[{"@value":"Eduardo Garin"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0931041X"},{"@type":"EISSN","@value":"1432198X"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/0931041X"}],"prism:publicationName":[{"@value":"Pediatric Nephrology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2009-09","prism:volume":"24","prism:number":"9","prism:startingPage":"1691","prism:endingPage":"1698"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm","http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1007/s00467-009-1214-x.pdf"},{"@id":"http://link.springer.com/article/10.1007/s00467-009-1214-x/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s00467-009-1214-x"}],"createdAt":"2009-06-02","modifiedAt":"2024-03-14","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002215521135872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rituximab Treatment for Nephrotic Syndrome in Children"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690473463296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711332327040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Apolipoprotein C-I Levels Are Associated with the Urinary Protein/Urinary Creatinine Ratio in Pediatric Idiopathic Steroid-Sensitive Nephrotic Syndrome: A Case Control Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641243482112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659604832384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593786273024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204339619968","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Minimal change disease:a “two hit” podocyte immune disorder?"},{"@value":"Minimal change disease:a ^|^ldquo;two hit^|^rdquo; podocyte immune disorder?"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204340089600","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"特発性ネフローゼ症候群の発症機序"},{"@language":"en","@value":"Pathogenic mechanism of childhood idiopathic nephrotic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204340288512","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Regulatory T Cell and Nephrotic Syndrome"},{"@value":"制御性T細胞とネフローゼ症候群"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206432414336","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"小児ネフローゼ症候群の免疫学的背景"},{"@language":"en","@value":"Immunological Background of Nephrotic Syndrome in Children"},{"@language":"ja-Kana","@value":"ショウニ ネフローゼ ショウコウグン ノ メンエキガクテキ ハイケイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390283659867410560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s00467-009-1214-x"},{"@type":"CROSSREF","@value":"10.1007/s40124-014-0065-5_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.1007/s12519-015-0003-9_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.1155/2017/6392843_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.3165/jjpn.25.137_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.4264/numa.74.87_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.3165/jjpn.25.64_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.3837-19_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfs543_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.3390/nu13020365_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.1016/s0140-6736(14)60541-9_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"},{"@type":"CROSSREF","@value":"10.3165/jjpn.rv.2015.0003_references_DOI_DlUGZST7VE06cBYeZzEjHKJjx7T"}]}